TEAM Technologies is expanding its medtech manufacturing capabilities with the purchase of Duke Empirical Inc. (Duke) for an undisclosed sum.

The deal broadens TEAM’s prowess in the minimally invasive, cardiology, and interventional markets, providing customers with a fully integrated, turnkey solution that combines Duke’s specialized front-end design and catheter expertise with TEAM’s comprehensive capability set and global manufacturing footprint. Duke designs, develops, and manufactures medical devices focused on advanced catheters and minimally invasive delivery systems.

Based in Morgan Hill, Calif., Duke touts deep technical expertise and innovation in catheter design, complex medical extrusion, and high precision assembly. The company serves top-tier global OEMs with a differentiated suite of capabilities, proprietary technologies, and a state-of-the-art facility. Specifically, Duke manufactures various catheters, including those used for minimally invasive structural heart, cardiovascular, neurovascular, urology and kidney-related procedures, while offering custom design and development services for catheter-based medical devices including guide catheters, balloon dilation catheters, and ultrasound catheters.

“This is a pivotal step in our strategy to become the full service partner of choice for healthcare OEMs in high-growth, high-acuity end markets,” TEAM Tech President/CEO Marshall White said. “With Duke’s complementary capabilities and innovative solutions, we are expanding the breadth and depth of services we offer to our partners while advancing our mission of Helping Those Who Help Others.”

Duke’s devices play a critical role in minimally invasive procedures, particularly in interventional and structural heart applications. Its advanced catheter systems, including custom and steerable designs, enable clinicians to navigate complexity and deliver therapies with precision in high-risk cardiovascular interventions. These mission-critical components improve access, efficiency, and outcomes in life-saving procedures, making Duke’s technologies foundational to the development of next-generation therapies.

“We’re thrilled to bring our expertise in minimally invasive device design, development and manufacturing to TEAM’s platform,” Duke Founder/CEO Robert LaDuca stated. “This partnership gives us the scale, talent, and infrastructure to continue driving innovation and improve outcomes for patients worldwide.”

Houlihan Lokey served as financial advisor and Goodwin Procter LLP served as legal advisor to TEAM Technologies and Arlington Capital Partners.

Headquartered in Knoxville, Tenn., with facilities throughout the United States and international facilities in Mexico and Singapore, TEAM Technologies is a specialized end-to-end outsourced manufacturer of mission-critical, single-use medical devices. The company has an array of advanced and vertically integrated manufacturing solutions servicing top medical device and pharmaceutical OEMs. TEAM Technologies leverages seamless, turnkey processes and innovation to simplify and improve its customers’ supply chains.

Duke Empirical specializes in medical device design and development, precision custom extrusion, high performance catheter manufacturing, medical device component assembly, and finished goods assembly and packaging.